C25.0

Clinical Causes: Genetic mutations due to inherited or acquired genetic factors Chronic inflammation of the pancreas (pancreatitis) Lifestyle factors such as smoking, excessive alcohol consumption, and obesity Diet high in processed foods and red meats Family history of pancreatic cancer or other related cancers Certain genetic syndromes that predispose individuals to pancreatic tumors

Key Symptoms: Jaundice (yellowing of the skin and eyes) Upper abdominal pain that may radiate to the back Unexplained weight loss Loss of appetite Nausea and vomiting New-onset diabetes or worsening blood sugar control Dark urine and pale stools General weakness and fatigue

Diagnosis Path: Imaging: Computed tomography (CT) scans or magnetic resonance imaging (MRI) help visualize the tumor and assess its size and spread. Endoscopic ultrasound (EUS) allows for detailed imaging and tissue sampling via biopsy. Blood tests, including tumor markers like CA 19-9, can support the diagnosis but are not definitive. If needed, additional procedures such as endoscopic retrograde cholangiopancreatography (ERCP) can be performed to examine pancreatic ducts and obtain tissue samples.

Treatment Protocols: Surgical removal: The Whipple procedure (pancreaticoduodenectomy) is the most common surgery for tumors in the head of the pancreas. It involves removing the head of the pancreas along with parts of the stomach, duodenum, and other nearby tissues. Chemotherapy: Drugs may be used to shrink the tumor before surgery, eliminate remaining cancer cells after surgery, or as a primary treatment if surgery isn't an option. Radiation therapy: Often combined with chemotherapy (chemoradiation) to target the tumor more precisely. Targeted therapy and immunotherapy: These are emerging treatments that may be considered based on specific genetic markers of the tumor. Palliative care: For advanced cases, treatments focus on relieving symptoms and improving quality of life.